Tackling Inflammatory Bowel Diseases: Targeting Proinflammatory Cytokines and Lymphocyte Homing

被引:17
|
作者
Song, Yijie [1 ]
Yuan, Man [1 ]
Xu, Yu [1 ]
Xu, Hongxi [2 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai 201203, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Shanghai 201203, Peoples R China
关键词
inflammatory bowel disease; cytokines; lymphocyte homing; LONG-TERM SAFETY; CHRONIC INTESTINAL INFLAMMATION; ACTIVE CROHNS-DISEASE; OPEN-LABEL EXTENSION; ULCERATIVE-COLITIS; MAINTENANCE THERAPY; INDUCTION THERAPY; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; ANTI-TL1A ANTIBODY;
D O I
10.3390/ph15091080
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Inflammatory bowel diseases (IBDs) are characterized by chronic inflammatory disorders that are a result of an abnormal immune response mediated by a cytokine storm and immune cell infiltration. Proinflammatory cytokine therapeutic agents, represented by TNF inhibitors, have developed rapidly over recent years and are promising options for treating IBD. Antagonizing interleukins, interferons, and Janus kinases have demonstrated their respective advantages in clinical trials and are candidates for anti-TNF therapeutic failure. Furthermore, the blockade of lymphocyte homing contributes to the excessive immune response in colitis and ameliorates inflammation and tissue damage. Factors such as integrins, selectins, and chemokines jointly coordinate the accumulation of immune cells in inflammatory regions. This review assembles the major targets and agents currently targeting proinflammatory cytokines and lymphatic trafficking to facilitate subsequent drug development.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases
    Strober, Warren
    Fuss, Ivan J.
    [J]. GASTROENTEROLOGY, 2011, 140 (06) : 1756 - U82
  • [2] Lymphocyte Homing Antagonists in the Treatment of Inflammatory Bowel Diseases
    Saruta, Masayuki
    Papadakis, Konstantinos A.
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (03) : 581 - +
  • [3] PHYSIOLOGICAL AND MOLECULAR MECHANISMS OF LYMPHOCYTE HOMING IN INFLAMMATORY BOWEL DISEASES
    MATUCHANSKY, C
    [J]. M S-MEDECINE SCIENCES, 1994, 10 (8-9): : 892 - 893
  • [4] Degeneration of the Pericryptal Myofibroblast Sheath by Proinflammatory Cytokines in Inflammatory Bowel Diseases
    Francoeur, Caroline
    Bouatrouss, Yamina
    Seltana, Amira
    Pinchuk, Iryna V.
    Vachon, Pierre H.
    Powell, Don W.
    Sawan, Basem
    Seidman, Ernest G.
    Beaulieu, Jean-Francois
    [J]. GASTROENTEROLOGY, 2009, 136 (01) : 268 - 277
  • [5] Cytokines in inflammatory bowel diseases
    Neurath, Markus
    [J]. CYTOKINE, 2015, 76 (01) : 62 - 62
  • [6] Bacterial Induction of Proinflammatory Cytokines in Inflammatory Bowel Disease
    Klapproth, Jan-Michael A.
    Sasaki, Maiko
    [J]. INFLAMMATORY BOWEL DISEASES, 2010, 16 (12) : 2173 - 2179
  • [7] B Lymphocyte intestinal homing in inflammatory bowel disease
    Defendenti, Caterina
    Sarzi-Puttini, Piercarlo
    Grosso, Silvia
    Croce, Annamaria
    Senesi, Olivia
    Saibeni, Simone
    Bollani, Simona
    Almasio, Piero Luigi
    Bruno, Savino
    Atzeni, Fabiola
    [J]. BMC IMMUNOLOGY, 2011, 12
  • [8] B Lymphocyte intestinal homing in inflammatory bowel disease
    Caterina Defendenti
    Piercarlo Sarzi-Puttini
    Silvia Grosso
    Annamaria Croce
    Olivia Senesi
    Simone Saibeni
    Simona Bollani
    Piero Luigi Almasio
    Savino Bruno
    Fabiola Atzeni
    [J]. BMC Immunology, 12
  • [9] Cytokines in the pathogenesis of inflammatory bowel diseases
    Jose Leon, Alberto
    Antonio Garrote, Jose
    Arranz, Eduardo
    [J]. MEDICINA CLINICA, 2006, 127 (04): : 145 - 152
  • [10] Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease
    Mitselou, Antigony
    Grammeniatis, Vasileios
    Varouktsi, Anna
    Papadatos, Stamatis S.
    Katsanos, Konstantinos
    Galani, Vasiliki
    [J]. INTESTINAL RESEARCH, 2020, 18 (01) : 115 - 120